Onconetix, Inc. (ONCO)
0.6967
+0.02
(+3.32%)
USD |
NASDAQ |
Sep 03, 11:20
Onconetix Cash from Operations (Annual) : -9.678M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -9.678M |
| December 31, 2024 | -10.90M |
| December 31, 2023 | -13.58M |
| December 31, 2022 | -8.699M |
| Date | Value |
|---|---|
| December 31, 2021 | -2.044M |
| December 31, 2020 | -1.730M |
| December 31, 2019 | -0.8251M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Aprea Therapeutics, Inc. | -12.89M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |
| Savara, Inc. | -101.04M |